Financial Data and Key Metrics Changes - The company achieved 3.4% organic revenue growth in Q3, with a balance of 1.8% from price and 1.6% from volume mix [3][6] - Reported revenue grew 0.7% in Q3, impacted by a 2.3% drag from divestments and 0.4% from foreign exchange [6][7] - The company is on track to deliver its full-year guidance, expecting organic revenue growth of around 3.5% for 2025 [15][16] Business Line Data and Key Metrics Changes - Oral health grew 6.9% in Q3, driven by innovation-led premiumization and geographic expansion [7][8] - The business line for pain relief grew 3.7%, with Panadol showing high single-digit growth [8][9] - Respiratory health declined 1.8%, influenced by the previous year's elevated COVID cases [9][10] - Digestive health grew 2.1%, supported by innovations like TUMS Gummy Bites Plus [9][10] Market Data and Key Metrics Changes - North America delivered organic revenue growth of 0.4%, driven by 0.7% price increase, while volume mix decreased by 0.3% [10][12] - EMEA and LATAM saw organic revenue increase of 5.3%, with price at 3.5% and volume mix at 1.8% [12][13] - Asia-Pacific experienced organic revenue growth of 5.1%, with strong performance in India and Southeast Asia [13][14] Company Strategy and Development Direction - The company focuses on innovation-led premiumization to drive category growth and expand market reach [4][6] - Continued investment in supply chain productivity and cost discipline is emphasized to enhance flexibility and agility in P&L [5][6] - The company aims to strengthen its innovation pipeline and improve net revenue management in North America [11][22] Management's Comments on Operating Environment and Future Outlook - Management noted a challenging consumer backdrop in North America but highlighted outperformance in oral health and digestive health [3][10] - The company expects continued strong growth in Q4, driven by salesforce investment and an improving macro environment [14][15] - Management remains confident in returning to growth in North America next year, with actions in place to address inventory levels [22][66] Other Important Information - The company completed EUR 500 million in share buybacks for 2025 [6] - Significant progress has been made in reducing SKUs by 19%, improving gross margin and working capital [5][80] Q&A Session Summary Question: North America performance and future expectations - Management explained that the sequential improvement in North America was driven by reduced drag from smokers' health and better performance in oral and digestive health [20][21] - Guidance for Q4 suggests around 1% decline, reflecting tough comparatives from the prior year [21][22] Question: Innovation pipeline and cold/flu season outlook - Management confirmed a strong innovation pipeline across categories and noted that the cold and flu season's variability impacts guidance [28][30] Question: Channel dynamics and inventory management - Management discussed the differences in inventory levels across channels, with a focus on ensuring appropriate stock levels for growth next year [35][66] Question: Consumer behavior and market performance - Management highlighted a bifurcated consumer environment, with varying performance across categories and channels [41][42] Question: Oral care business performance - Management acknowledged softer performance in certain oral care brands but remains positive about overall oral health growth [70][72]

Performance Overview - Alluvial Fund achieved a return of 15.5% in Q3 2025, with a total return of 33.6% year-to-date, outperforming benchmark indexes [3][8] - This performance marks the third-best quarterly result in the fund's nine-year history [3] Portfolio Highlights - The largest position in the portfolio is Zegona Communications, which is undergoing significant asset sales that will enhance cash flow and reduce leverage [11][12] - FitLife Brands acquired Irwin Naturals out of bankruptcy for $42.5 million, funded by cash and bank debt, and is expected to perform well due to strong leadership [15][16] - PHI Group, a helicopter operator, is noted for its profitability and potential for a sale or public listing, trading at half the value of peers [29] Market Insights - Concerns are raised about the sustainability of the current market rally, particularly regarding speculative companies like Rigetti Computing, which has a market value of $18 billion despite minimal revenue [9][10] - The fund maintains a cautious approach, focusing on companies with durable cash flows and valuable assets [10] Sector and Geographic Allocation - The fund's geographic allocation is primarily in the United States (59.1%), followed by the United Kingdom (23.2%) and Eurozone (10.1%) [23] - Sector allocation includes Communications (21.0%), Consumer Staples (20.7%), and Real Estate (12.9%) [24] Notable Developments - NewPrinces Group plans to list a minority stake in UK food producer Princes, potentially realizing significant value from its investment [19] - Unidata SpA, an Italian broadband provider, has seen cash flow grow by 67% since 2022, yet its shares are down nearly 40%, indicating a potential undervaluation [25] Risk Management - The fund is trimming its position in Zegona for risk control, emphasizing the importance of managing exposure to unforeseen negative events [14] - The fund's allocation to Expert Markets securities is limited to 10% to manage liquidity risk [28]